Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.59 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.59 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.59 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MTOR | P42345 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.56 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CDA | P32320 | 1/20 | 0.53 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12594002 | 1.00 | SLC28A1 (0.59) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL4293684 | 1.00 | SLC28A1 (0.59) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL9293560 | 1.00 | SLC28A1 (0.59) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL13657982 | 1.00 | SLC28A1 (0.59) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL2115033 | 0.84 | LMNA (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL21184966 | 0.84 | LMNA (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL6676522 | 0.84 | LMNA (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL16179302 | 0.80 | SLC28A1 (0.59) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL7028245 | 0.79 | MAPT (0.63) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL7028251 | 0.79 | MAPT (0.63) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268993-A1 | ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS | THERIVA BIOLOGICS, INC. | 2025-08-28 | — | — | US | claimed |
| US-12318434-B2 | Alkaline phosphate-based oncology treatments | THERIVA BIOLOGICS, INC. (US) | 2025-06-03 | — | — | US | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-115998885-B | Inhibitor combination and application thereof in preparation of medicines for treating MYC high-expression cancers | 上海科技大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-4238571-A1 | APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS | OnQuality Pharmaceuticals China Ltd. (CN) | 2023-09-06 | — | — | EP | claimed |
| WO-2023142996-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | 上海岸阔医药科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| CN-116437930-A | Use of uridine derivatives in the preparation of medicaments | 上海岸阔医药科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116367842-A | Application of thymidine derivative in preparing medicine | 上海岸阔医药科技有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-115998885-A | Inhibitor combination and application thereof in preparation of medicines for treating MYC high-expression cancers | 上海科技大学 | 2023-04-25 | — | — | CN | claimed |
| EP-0594667-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-05-04 | — | — | EP | claimed |
| EP-0577725-A1 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1994-01-12 | — | — | EP | claimed |
| EP-0539493-A4 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | — | 1993-06-02 | — | — | EP | claimed |
| EP-0539493-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES. | BODOR NICHOLAS S (US) | 1993-05-05 | — | — | EP | claimed |
| WO-1993001202-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1993-01-21 | — | — | WO | claimed |
| US-5177064-A | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1993-01-05 | — | — | US | claimed |
| EP-0359347-B1 | COVALENTLY-LINKED COMPLEXES AND METHODS FOR ENHANCED CYTOTOXICITY AND IMAGING | NEORX CORPORATION (US) | 1992-12-23 | — | — | EP | claimed |
| WO-1992017185-A1 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1992-10-15 | — | — | WO | claimed |
| WO-1992000988-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | BODOR NICHOLAS S (US) | 1992-01-23 | — | — | WO | claimed |
| EP-0359347-A2 | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging | NEORX CORPORATION (US) | 1990-03-21 | — | — | EP | claimed |